drugpricing

Senior officials from the Trump administration say they have reached two important agreements with Eli Lilly and Novo Nordisk that will lower the prices of major obesity drugs.

These medicines have been in huge demand, but the high cost has kept many people from accessing them.

The new deals aim to ease that burden and expand availability for millions of Americans. If fully implemented, this could become one of the most meaningful healthcare shifts in years.

#USPolicy
#HealthUpdate
#DrugPricing